PECAM1 and angiosarcoma: To further validate these observations for this study, we previously stained the CTCs of an angiosarcoma patient with CD31, an angiosarcoma biomarker, and reinforced this argument by staining the CTCs of a patient with embryonal rhabdomyosarcoma with smooth muscle actin (Figure 1E) (17).